Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Extracorporeal Shock Wave Therapy on Chronic Neurogenic Heterotopic Ossification in Traumatic Brain Injured Patients

NCT02331628 is registered in ClinicalTrials.gov with Loewenstein Hospital as lead sponsor.

NCT NCT02331628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02331628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Extracorporeal Shock Wave Therapy on Chronic Neurogenic Heterotopic Ossification in Traumatic Brain Injured Patients
Lead sponsor
Loewenstein Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2014
Completion date
September 13, 2018
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tbi traumatic brain injury